Skip to Content

Clinical Trials Search Results

Showing 1-10 of 18

Sorted By:

  • A221102

    Randomized Double-Blind Placebo Controlled Study of Subcutaneous Testosterone in the Adjuvant Treatment of Postmenopausal Women with Aromatase Inhibitor Induced Arthralgias

  • Alliance A011104 (Not open to Accrual Yet)

    Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast Cancer

  • ANZGOG-0902-GOG-0274

    A phase 3 Trial of Adjuvant Chemotherapy as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: THE OUTBACK TRIAL


    Studying Interventions For Managing Patients With Chronic Myeloid Leukemia In Chronic Phase: The 5-Year Prospective Cohort Study (SIMPLICITY)

  • CALGB 30607

    Randomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib (NSC #736511, IND #74019) as Maintenance Therapy in Non-Progressing Patients Following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB/IV Non-Small Cell Lung Cancer

  • CALGB-40903

    Phase II Study Neoadjuvant Letrozole for Postmenopausal Women with Estrogen Receptor Positive Ductal Carcinoma in SITU (DCIS)

  • CCCWFU 98213 (PREVENT)

    Preventing Anthracycline Cardiovascular Toxicity with Statins

  • ECOG E5508

    Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC

  • GOG 0212

    A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paclitaxel or CT 2103 (IND# 70177) Versus No Treatment Until Documented Relapse in Women With Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancer who Achieve a Complete Clinical Response to Primary Platinum/Taxane Chemotherapy

  • GOG 0213

    A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (Or Gemcitabine)Alone or in Combination with Bevacizumab (NSC #704865, IND #113912) followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer

Page of 2, showing trials 1-10 of 18

Also in this Section